Found 13 matching trials
Combination Therapy for Age-Related Macular Degeneration.
PHASE2The primary purpose of the study is to investigate whether patients with Ch...
Location
The University of Alberta and Capital Health
Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
NAIn this study, we aim to evaluate the efficacy and safety of an individuali...
Location
Singapore National Eye Centre
Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
PHASE1To demonstrate the efficacy of ranibizumab in combination with reduced-flue...
Location
Multiple Locations
Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
PHASE1The purpose of this study is to report the treatment effect and safety of c...
Location
Ophthalmology Department SUN
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
PHASE4In this pilot study the researchers will evaluate the safety and efficacy o...
Location
Eagle Mountain Vision
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy
PHASE4Study the effectiveness of the treatment detachment of retinal pigment epit...
Location
Universidade Federal de São Paulo - Escola Paulista de Medicina
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
NAAnti-VEGF therapy has been proven efficacious for the wet (neovascular) for...
Location
Multiple Locations
Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD)
NAThe purposes of this study is to determine if combination reduced fluence p...
Location
Multiple Locations
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
PHASE3This study evaluated the effect of combination therapy with verteporfin pho...
Location
Novartis Investigative Site
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
PHASE2The objective of this study is to determine if combination therapy (reduced...
Location
Multiple Locations